503A compounding facility products from central admixture pharmacy services, INC.:1322517

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N90024D00004
Awardee
Awarding agency
Task orders
3 $1,297,564 obligated

Award facts

Opportunity
  • 23503 Solicitation number
Combined order value
$1,297,564 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 22% used
$6,000,000.00
Maximum order
$500,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center has awarded a $6 million, single-award Indefinite Delivery Contract (IDC) to Central Admixture Pharmacy Services Inc. (Caps) for the provision of 503A compounded sterile preparations and parenteral nutrition solutions. Caps is a for-profit organization that operates as both a 503A traditional pharmacy and a 503B outsourcing facility, specializing in customized intravenous mixtures, sterile admixtures, total parenteral nutrition solutions, and other compounded sterile preparations.

The IDC has a performance period through September 30, 2025. Under the contract, the NIH Clinical Center has issued two firm fixed-price delivery orders to-date. The first, valued at $750,000, is for 503A compounding services, while the second, also $750,000, is for 503B compounding services. Both delivery orders have completion dates in September 2024 and do not carry any set-aside designations. Caps has received over 50 prime federal contracts since 2019, primarily to support patient care programs at various government healthcare facilities, including those operated by the Department of Veterans Affairs, Defense Health Agency, Department of the Army, Department of the Navy, and Indian Health Service.

Task orders

Task order Ordering agency Obligated Awarded
Procurement of 503A and 503B compounded products 75N90025F00001 NIH Clinical Center $547,564
503B compounding services 75N90024F00002 NIH Clinical Center $0
503A compounding services 75N90024F00001 NIH Clinical Center $750,000

Transactions

Action Obligated Date
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N90024D00004?

75N90024D00004 was awarded to Central Admixture Pharmacy Services, Inc. by NIH Clinical Center (National Institutes of Health) on April 17, 2024.

How much is contract 75N90024D00004 worth?

Orders under 75N90024D00004 have obligated $1,297,564. 75N90024D00004's own ceiling is $6,000,000. A single order can be worth up to $500,000.

How many orders have been placed under contract 75N90024D00004?

3 orders have been placed under 75N90024D00004, the latest on October 1, 2024.

Who can order from contract 75N90024D00004?

75N90024D00004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N90024D00004 competed?

The extent of competition for 75N90024D00004 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV